11 March 2013
Women that take aspirin could be at a significantly lower risk of developing melanoma, according to a new study.
Published in the American Cancer Society Journal, the research suggests that aspirin's anti-inflammatory effects could help to protect against a skin cancer diagnosis and the benefits are greater the longer a female takes it.
This is based on observations of 59,806 caucasian US women aged between 50 and 79 for an average of 12 years.
Leader of the study Jean Tang, of Stanford University School of Medicine, claims that females who used aspirin had a 21 per cent lower risk of melanoma relative to non-users.
What's more, each incremental increase in duration of aspirin use yielded an 11 per cent lower risk of melanoma.
Using this logic, a woman that has used aspirin for five or more years has a 30 per cent lower melanoma risk than a female that does not use the drug.
Currently, it is unknown if the same effect occurs in males and further research is needed.
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.